杆菌A疫苗全球需求和投资回报预测,以告知行业的研发优先级
Donald R Walkinshaw1, Meghan E E Wright2, Marni Williams2
1Shift Health, Toronto, Canada. dwalkinshaw@shifthealth.com.
NPJ vaccines
|August 9, 2023
概括
尽管疾病负担很大,但对A型链球菌疫苗的投资很低. 这个研究研究这个研究.
科学领域:
- * 传染病流行病学
- * 疫苗经济学
- * 制药市场分析
背景情况:
- *A组链球菌 (链球菌A) 导致全球疾病负担显著.
- * 对于A型链球菌疫苗的研发 (R&D) 投资特别低.
- * 缺乏经济建模阻碍了对A型链球菌疫苗开发的投资.
研究的目的:
- * 开发一个全球需求和财务预测模型,用于假设的A型链球菌疫苗.
- * 分析A型链球菌疫苗开发的潜在收入,利和投资回报.
- * 通过不同的市场情景来评估A型链杆菌疫苗的商业可行性.
主要方法:
- *构建一个新的全球需求和金融预测模型.
- *包括对资本投资回报的净现值 (NPV) 分析.
- * 针对跨国制药公司和发展中国家制造商的场景建模,考虑婴儿和儿童人口的私营和公共市场.
主要成果:
- * 在各种开发者场景和目标人群中计算出正的NPV.
- *该模型表明,A型链球菌疫苗的商业市场是可行的.
- * 财务预测表明,A型链球菌疫苗的开发和推广可能会带来利.
结论:
- *这项研究表明,投资A型链球菌疫苗研发有强有力的商业理由.
- *研究结果表明,对A型链球菌疫苗开发的优先考虑和投资是有必要的.
- *经济预测模型可以为行业的决策提供信息,并鼓励研发资金.
更多相关视频
13:47Opsono-Adherence Assay to Evaluate Functional Antibodies in Vaccine Development Against Bacillus anthracis and Other Encapsulated Pathogens
Published on: May 19, 2020
3.5K
09:14An Improved and High Throughput Respiratory Syncytial Virus RSV Micro-neutralization Assay
Published on: January 26, 2019
10.9K
相关概念视频
Microorganisms in Medicine and Therapeutics
54
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
54
Preclinical Development: Overview
4.5K
Preclinical development consists of a series of tests that ensure the safety and efficacy of a new therapeutic compound before it is tested in humans. There are four main phases to this process. First, safety pharmacology tests are conducted to ensure the drug does not produce any acutely harmful effects. These tests examine parameters such as bronchoconstriction, cardiac dysrhythmias, blood pressure changes, and ataxia. Next, preliminary toxicological testing is performed to determine the...
4.5K
Clinical Trials: Overview
3.0K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
3.0K
Vaccinations
44.7K
Overview
44.7K
